Benznidazole

Benznidazole (CAS No.: 22994-85-0) is a synthetic nitroimidazole class small molecule broadly categorized as an antiprotozoal research compound and is widely used in parasitology and infectious disease discovery programs focused on Trypanosoma cruzi and related kinetoplastid biology, where it serves as a mechanistic tool to investigate nitroreductase dependent bioactivation, redox stress associated macromolecular damage, disruption of parasite protein biosynthesis, modulation of parasite associated cytokine signaling profiles, and enhancement of host cell phagocytic responses in experimental systems; reported in vitro potency against susceptible parasite strains is generally described in the micromolar domain, including low micromolar activity in some strain specific assays, while activity can vary with parasite genotype, intracellular stage, exposure duration, and host cell context, and current preclinical workflows therefore employ benznidazole in cell based infection models, comparative susceptibility panels, resistance evolution studies, and combination screening paradigms to benchmark antiprotozoal effects and probe pathway level vulnerabilities, with concentrations or doses used in experiments typically depending on specific experimental designs and research objectives.